Table 4.
Complications | Curosurf | Survanta | P Value |
---|---|---|---|
Gestational age ≤32 weeks (N = 58) | |||
Number | 24 | 34 | |
Sepsis | 2 (8.3) | 5 (14.7) | 0.381 |
Pneumonia | 1 (4.2) | 4 (11.8) | 0.304 |
IVH | 6 (25) | 4 (11.8) | 0.189 |
Pulmonary hemorrhage | 3 (12.5) | 6 (17.6) | 0.594 |
NEC | 5 (20.8) | 3 (8.8) | 0.179 |
Pneumothorax | 2 (8.3) | 4 (11.8) | 0.514 |
ROP | 2 (8.3) | 1 (2.9) | 0.370 |
Total complications | |||
With complication | 12 (50) | 13 (38.2) | |
Without complication | 12 (50) | 21 (61.8) | |
Mortality | 1 (4.2) | 6 (17.6) | 0.221 |
Nasal CPAP | 3 (12.5) | 8 (23.5) | 0.291 |
ET Tube | 14 (58.3) | 18 (52.9) | 0.446 |
Gestational age > 32 weeks (N = 54) | |||
Number | 32 | 22 | |
Sepsis | 0 (0) | 0 (0) | – |
Pneumonia | 4 (12.5) | 7 (31.8) | 0.083 |
IVH | 1 (3.1) | 0 (0) | 0.593 |
Pulmonary hemorrhage | 0 (0) | 0 (0) | – |
NEC | 0 (0) | 0 (0) | – |
Pneumothorax | 0 (0) | 1 (4.5) | 0.407 |
ROP | 1 (3.1) | 0 (0) | 0.593 |
Total complications | |||
With complication | 6 (18.8) | 7 (31.8) | |
Without complication | 26 (81.2) | 15 (68.2) | |
Mortality | 1 (3.1) | 0 (0) | 0.403 |
Nasal CPAP | 8 (25) | 6 (27.3) | 0.547 |
ET Tube | 3 (9.4) | 9 (40.9) | 0.008 |